These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23735729)

  • 21. Effect of hyperuricemia on the blood pressure response to antihypertensive agents in hospitalized elderly patients.
    Zhu P; Lin F; Lin C; Hong D; Lin K; Chen H
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):741-6. PubMed ID: 22964647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visit-to-visit variability of blood pressure: current knowledge and future research directions.
    Muntner P; Levitan EB
    Blood Press Monit; 2013 Aug; 18(4):232-8. PubMed ID: 23676615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression to hypertension in non-hypertensive children following renal transplantation.
    Sinha MD; Gilg JA; Kerecuk L; Reid CJ;
    Nephrol Dial Transplant; 2012 Jul; 27(7):2990-6. PubMed ID: 22287656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.
    Rossignol P; Kessler M; Zannad F
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):59-64. PubMed ID: 23165110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of renin angiotensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients.
    Kawai T; Ohishi M; Onishi M; Takeya Y; Ito N; Kato N; Yamamoto K; Kamide K; Rakugi H
    Am J Hypertens; 2012 Dec; 25(12):1249-55. PubMed ID: 22932704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effectiveness of aliskiren for the 'real-world' management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study).
    Verpooten GA; Aerts A; Coen N; Vancayzeele S; Hermans C; Bowles J; MacDonald K; Abraham I; Lee CS
    Int J Clin Pract; 2011 Jan; 65(1):54-63. PubMed ID: 21155943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should we shift toward higher blood pressure targets in patients with chronic kidney disease?
    Gentile G; Strippoli GF
    J Nephrol; 2011; 24(6):673-85. PubMed ID: 22058026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.
    Gosmanova EO; Kovesdy CP
    Curr Cardiol Rep; 2016 Sep; 18(9):88. PubMed ID: 27448402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.
    Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM;
    Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between visit-to-visit variability in blood pressure measured in the office and antihypertensive drugs: the J-HOME-Morning study.
    Obara T; Kikuya M; Kobayashi Y; Ishikura K; Ikeda U; Ishikuro M; Metoki H; Mano N; Kuriyama S; Ohkubo T; Imai Y;
    Clin Exp Hypertens; 2013; 35(4):285-90. PubMed ID: 23557293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive therapy in nondiabetic chronic kidney disease: a review and update.
    Der Mesropian PJ; Shaikh G; Cordero Torres E; Bilal A; Mathew RO
    J Am Soc Hypertens; 2018 Mar; 12(3):154-181. PubMed ID: 29396103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].
    Villeneuve F; Rosenbaum D; Gury C; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):198-202. PubMed ID: 22677179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension goals in advanced-stage kidney disease.
    Hopkins K; Bakris GL
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S92-4. PubMed ID: 19996011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.